ASX Markets

4Dmedical

Price Movement: Shares surged as much as 38% in early trade, reaching a record high of $6.40.

The primary catalyst for today’s rally is the announcement that 4DMedical’s flagship CT:VQ™ technology has been deployed at the Mayo Clinic in the United States.

• Significance: Mayo Clinic is globally recognized as one of the world’s leading healthcare institutions. This partnership is viewed by the market as a “landmark moment” and a top-tier endorsement of 4DMedical’s respiratory imaging technology.
• Agreement Details: The clinic will integrate CT:VQ into clinical workflows for ventilation and perfusion analysis, allowing clinicians to evaluate the technology across multiple use cases.

### Market Reaction

Commercial Momentum: This marks the company’s sixth major U.S. deployment in just seven months since receiving FDA clearance in September 2025. Other major sites include the Cleveland Clinic, Stanford, UC San Diego Health, University of Chicago Medicine, and the University of Miami.